Am. J. Respir. Crit. Care Med., Volume 156, Number 6, December 1997, 1820-1824

Implementation of Bronchoscopic Techniques in the Diagnosis of Ventilator-associated Pneumonia to Reduce Antibiotic Use

MARC J. M. BONTEN, DENNIS C. J. J. BERGMANS, ELLEN E. STOBBERINGH, SIEBE van der GEEST, PETER W. DE LEEUW, FRANK H. van TIEL, and CARLO A. GAILLARD

Departments of Internal Medicine and Medical Microbiology, University Hospital Maastricht, Maastricht; and Department of Internal Medicine, Eemland Hospital, Amersfoort, The Netherlands

In intensive care units, a large proportion of antibiotics are prescribed for presumed episodes of ventilator-associated pneumonia (VAP). VAP is usually diagnosed on a combination of clinical, radiographic, and microbiologic criteria with a high sensitivity but low specificity for VAP. As a result, patients may receive antibiotics unnecessarily. Specificity can be increased by the addition of quantitative cultures of samples of protected specimen brush (PSB) and bronchoalveolar lavage (BAL) to the diagnostic criteria. We prospectively analyzed the effects of implementation of PSB and BAL in the diagnosis of VAP on antibiotic prescription. PSB and/or BAL were performed in patients who fulfilled the clinical, radiographic, and microbiologic criteria for VAP. Based on quantitative cultures of PSB and/or BAL, patients were categorized into three groups: VAP microbiologically proven (Group 1; n = 72); clinical suspicion of VAP not confirmed microbiologically (Group 2; n = 66); and patients in whom bronchoscopy could not be performed (Group 3; n = 17). In Group 1, antibiotic therapy was instituted empirically in 40 patients (56%) (Group 1a) and after obtaining culture results in the other 32 patients (Group 1b). Adjustment of therapy, based on culture results, occurred in 14 (35%) patients in Group 1a. In Group 2, empiric therapy was instituted in 34 (52%) patients (Group 2a) and discontinued within 48 h in 17 of them (50%). In Group 3, 17 (100%) patients were treated with antibiotics. Among the 66 patients in whom a clinical suspicion of VAP was not confirmed, only 18 (27%) were treated with antibiotics, and antibiotic therapy was withheld in 48 (35%) of 138 patients who underwent bronchoscopy. Withholding of antibiotic therapy had no negative effect on the recurrence of a clinical suspicion of VAP or on mortality rates. We conclude that addition of bronchoscopic techniques to the criteria for VAP may help to reduce antibiotic use. However, the definite benefits and cost-effectiveness of these techniques should be analyzed in a randomized study.

This article has been cited by other articles:

				R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34. [Abstract] [Full Text] [PDF]

				C. F M Linssen, O. Bekers, M. Drent, and J. A Jacobs C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia Ann Clin Biochem, May 1, 2008; 45(3): 293 - 298. [Abstract] [Full Text] [PDF]

				K. A. Davis Ventilator-associated pneumonia: a review. J Intensive Care Med, July 1, 2006; 21(4): 211 - 226. [Abstract] [PDF]

				C. M. Luna, P. Aruj, M. S. Niederman, J. Garzon, D. Violi, A. Prignoni, F. Rios, S. Baquero, S. Gando, and for the Grupo Argentino de Estudio de la Neumonia Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Eur. Respir. J., January 1, 2006; 27(1): 158 - 164. [Abstract] [Full Text] [PDF]

				C. Brun-Buisson, M. Fartoukh, E. Lechapt, S. Honore, J.-R. Zahar, C. Cerf, and B. Maitre Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia Chest, August 1, 2005; 128(2): 533 - 544. [Abstract] [Full Text] [PDF]

				Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]

				F. Michel, B. Franceschini, P. Berger, J.-M. Arnal, M. Gainnier, J.-M. Sainty, and L. Papazian Early Antibiotic Treatment for BAL-Confirmed Ventilator-Associated Pneumonia: A Role for Routine Endotracheal Aspirate Cultures Chest, February 1, 2005; 127(2): 589 - 597. [Abstract] [Full Text] [PDF]

				D. E. Ost, C. S. Hall, G. Joseph, C. Ginocchio, S. Condon, E. Kao, M. LaRusso, R. Itzla, and A. M. Fein Decision Analysis of Antibiotic and Diagnostic Strategies in Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1060 - 1067. [Abstract] [Full Text] [PDF]

				J-Y. Fagon and J. Chastre Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Eur. Respir. J., August 1, 2003; 22(42_suppl): 77s - 83s. [Abstract] [Full Text] [PDF]

				R. M. Mehta and M. S. Niederman Nosocomial Pneumonia in the Intensive Care Unit: Controversies and Dilemmas J Intensive Care Med, July 1, 2003; 18(4): 175 - 188. [Abstract] [PDF]

				C. Brun-Buisson Antibiotic Therapy of Ventilator-Associated Pneumonia: In Search of the Magic Bullet Chest, March 1, 2003; 123(3): 670 - 673. [Full Text] [PDF]

				G. W. Waterer The Diagnostic Dilemma in Suspected Ventilator-Associated Pneumonia: One Size Will Never Fit All Chest, February 1, 2003; 123(2): 335 - 337. [Full Text] [PDF]

				J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]

				P. J. W. DENNESEN, A. J. A. M. van der VEN, A. G. H. KESSELS, G. RAMSAY, and M. J. M. BONTEN Resolution of Infectious Parameters after Antimicrobial Therapy in Patients with Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1371 - 1375. [Abstract] [Full Text]

				J. C. Pereira Gomes, W. L. Pedreira Jr., E. M. P. A. Araujo, F. G. Soriano, E. M. Negri, L. Antonangelo, and I. Tadeu Velasco Impact of BAL in the Management of Pneumonia With Treatment Failure : Positivity of BAL Culture Under Antibiotic Therapy Chest, December 1, 2000; 118(6): 1739 - 1746. [Abstract] [Full Text] [PDF]

				F. BLOT, B. RAYNARD, E. CHACHATY, C. TANCRÈDE, S. ANTOUN, and G. NITENBERG Value of Gram Stain Examination of Lower Respiratory Tract Secretions for Early Diagnosis of Nosocomial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1731 - 1737. [Abstract] [Full Text]

				M. J. M. Bonten, B. J. Kullberg, R. van Dalen, A. R. J. Girbes, I. M. Hoepelman, W. Hustinx, J. W. M. van der Meer, P. Speelman, E. E. Stobberingh, H. A. Verbrugh, et al. Selective digestive decontamination in patients in intensive care J. Antimicrob. Chemother., September 1, 2000; 46(3): 351 - 362. [Abstract] [Full Text] [PDF]

				R. S. Morehead and S. J. Pinto Ventilator-Associated Pneumonia Arch Intern Med, July 10, 2000; 160(13): 1926 - 1936. [Abstract] [Full Text] [PDF]

				J.-Y. Fagon, J. Chastre, M. Wolff, C. Gervais, S. Parer-Aubas, F. Stephan, T. Similowski, A. Mercat, J.-L. Diehl, J.-P. Sollet, et al. Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia: A Randomized Trial Ann Intern Med, April 18, 2000; 132(8): 621 - 630. [Abstract] [Full Text] [PDF]

				M. S. Niederman Bronchoscopy in Nonresolving Nosocomial Pneumonia Chest, April 1, 2000; 117(4_suppl_2): 212S - 218S. [Full Text] [PDF]

				D. K. Heyland, D. J. Cook, J. Marshall, M. Heule, B. Guslits, J. Lang, and R. Jaeschke The Clinical Utility of Invasive Diagnostic Techniques in the Setting of Ventilator-Associated Pneumonia Chest, April 1, 1999; 115(4): 1076 - 1084. [Abstract] [Full Text] [PDF]